Original Article
Copyright ©2010 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Nov 28, 2010; 16(44): 5582-5587
Published online Nov 28, 2010. doi: 10.3748/wjg.v16.i44.5582
Screening compounds against HCV based on MAVS/IFN-β pathway in a replicon model
Qiu-Xia Fu, Li-Cui Wang, Shuai-Zheng Jia, Bo Gao, Yong Zhou, Juan Du, Ying-Li Wang, Xiao-Hui Wang, Jian-Chun Peng, Lin-Sheng Zhan
Qiu-Xia Fu, Li-Cui Wang, Shuai-Zheng Jia, Bo Gao, Yong Zhou, Juan Du, Ying-Li Wang, Xiao-Hui Wang, Jian-Chun Peng, Lin-Sheng Zhan, Laboratory of Blood-Borne Virus, Beijing Institute of Transfusion Medicine, Beijing 100850, China
Author contributions: Zhan LS designed the research; Fu QX, Wang LC and Jia SZ performed the majority of experiments, and they contributed equally to this work; Gao B, Zhou Y, Du J, Wang YL, Wang XH and Peng JC analyzed the data and edited the manuscript.
Supported by The Natural Science Foundation of China, No. 30600330, No. 30671842, No. 30672488, No. 30700475, No. 30771919 and No. 30700757; the National High Technology Research and Development Program of China, No. 2008AA02Z132; Beijing Municipal Natural Science Foundation, No. 5082016; and Mega-projects of Science Research for the 11th Five-Year Plan, No. 2009ZX10004-4001
Correspondence to: Lin-Sheng Zhan, Professor, Laboratory of Blood-Borne Virus, Beijing Institute of Transfusion Medicine, 27(9) Tai Ping Road, Beijing 100850, China. lszhan91@yahoo.com
Telephone: +86-10-66931222 Fax: +86-10-66931292
Received: May 27, 2010
Revised: August 15, 2010
Accepted: August 23, 2010
Published online: November 28, 2010
Core Tip